Junyan completed her Dentistry at the Soochow University, China 2022. She transitioned into the realm of cancer immunology research within Dr. Elahi’s lab in October 2023. Her current focus is on identifying biomarkers for adverse effects in patients undergoing immune checkpoint blockade therapy. By delving into the intricate interplay of these elements, she aims to contribute to personalized medicine and improved patient outcomes. Let's collaborate on pioneering discoveries to enhance the efficacy and safety of cancer immunotherapy.